Literature DB >> 4904294

Appraisal of BC-105 in migraine prophylaxis.

O Sjaastad, P Stensrud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4904294     DOI： 10.1111/j.1600-0404.1969.tb01269.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  6 in total

Review 1.  Prophylaxis of migraine headache.

Authors:  Tamara Pringsheim; W Jeptha Davenport; Werner J Becker
Journal:  CMAJ       Date:  2010-02-16       Impact factor: 8.262

Review 2.  Treating migraine.

Authors:  C Clough
Journal:  BMJ       Date:  1989-07-15

3.  Lack of effect of the appetite stimulant pizotifen (BC 105) on the absorption of isonicotinylhydrazine.

Authors:  E E Ohnhaus; E Nüesch
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  Clinical observations with pizotifene (Sandomigran) in the treatment of nonmigrainous depressed women.

Authors:  C M Banki
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-03-07

Review 5.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 6.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.